dyskinesia PD LID

Related by string. * dyskinesias . Dyskinesia : levodopa induced dyskinesia . troublesome dyskinesia . primary ciliary dyskinesia . Tardive Dyskinesia TD . Tardive dyskinesia . Tardive dyskinesia TD / PS . Ping . Ps . Per . ping . P. : P aul . & P . Per Cent Stake . Ten Per Cent . Earnings Per Share . Ping An / lied . lid . Lis . Lied . li . LIS : Li Ning . Li Na . Na Li . Li Ka shing . Li ion battery . Li Ka Shing * *

Related by context. Frequent words. (Click for all words.) 71 pseudobulbar affect PBA 70 6R BH4 69 diabetic neuropathic pain 69 ADX# 67 administered subcutaneously 67 AVE# 67 Laquinimod 66 non alcoholic steatohepatitis 66 Phase IIa trial 66 phase IIa 66 rNAPc2 66 phenylketonuria PKU 66 placebo controlled clinical 65 carcinoid syndrome 65 LY# [003] 65 Ofatumumab 65 systemic lupus erythematosus SLE 65 Pivotal Phase III 65 active comparator 65 phase IIb 64 pertuzumab 64 pheochromocytoma 64 Topiramate 64 Phase IIa 64 Phase Ib clinical 64 luteinizing hormone releasing 64 Pivotal Phase 64 Phase III Clinical Trial 64 Phase 2a clinical 64 Neurodex 64 Amrubicin 64 Sym# 64 Drug Candidate 64 Voreloxin 64 zileuton 64 HCV protease inhibitor 64 Rivaroxaban 64 alvimopan 64 NGX# 64 MAP# 64 methylnaltrexone 64 Phase III Trial 64 BAY #-# 64 tezampanel 64 JANUMET 64 tanespimycin 64 multicenter randomized double 64 Phase IIa clinical 63 Monotherapy 63 ACTEMRA 63 blinded placebo controlled 63 Phase 2a 63 Phase Ib 63 PRX # 63 Acute Myeloid Leukemia AML 63 Phenoptin 63 humanized anti 63 RG# [001] 63 double blinded placebo 63 Completes Enrollment 63 Pivotal Trial 63 humanized monoclonal antibody 63 ALN TTR# 63 ropinirole 63 superficial bladder cancer 63 TELCYTA 63 injectable formulation 63 lacosamide 63 anakinra 63 SCH # 63 NOXAFIL 63 hypercalcemia 63 pegylated 63 Clinical Trial Results 63 tolvaptan 63 KNS # 63 Phase IIb clinical 63 phase 2a 63 Phase 2b study 62 Naproxcinod 62 Alemtuzumab 62 SILENOR TM 62 placebo controlled randomized 62 angiogenesis inhibitor 62 Pirfenidone 62 hypoparathyroidism 62 opioid induced constipation 62 overactive bladder OAB 62 receptor agonist 62 ocrelizumab 62 fibromyalgia syndrome 62 diabetic macular edema DME 62 Irinotecan 62 Linaclotide 62 safinamide 62 single ascending dose 62 injection USP 62 hypercholesterolemia 62 receptor antagonists 62 Ostarine 62 teduglutide

Back to home page